From mice to humans—divergent strategies for intestinal homeostasis and regeneration
FEBS Letters · 2026-11 · 600 (21) · 3186-3200
DOI: 10.1002/1873-3468.70387 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift FEBS Letters, online erschienen am 19.06.2026. Verfasst von Keiko Ishikawa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrated Medicine and Biochemistry, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Regeneration, Homeostasis, Stem Cells, Intestinal Mucosa. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, AMED, Japan Science and Technology Agency.
Abstract (Originalsprache)
The intestinal epithelium is maintained by stem cells that balance self‐renewal and differentiation to sustain homeostasis and enable regeneration after injury. Recent advances—including organoid culture, genome editing, orthotopic xenotransplantation, and somatic mutation–based analysis—have created new opportunities to investigate intestinal stem cell (ISC) dynamics in humans. These studies have revealed striking species‐specific differences: whereas mouse LGR5 + ISCs divide daily and are chemo‐sensitive, human colonic LGR5 + stem cells are predominantly slow‐cycling and chemo‐resistant. Consistent with this reduced cycling, human ISCs accumulate somatic mutations more slowly than those of mice. Across mammals, ISC proliferation rates inversely correlate with lifespan, a relationship thought to minimize mutation accumulation and reduce cancer risk, in line with Peto's paradox. Regenerative responses in both mice and humans can involve fetal‐like reprogramming driven by YAP and other signaling pathways, yet the extent of species differences in intestinal regenerative capacity remains unclear. This review synthesizes current insights into ISC kinetics, injury responses, and evolutionary adaptations, highlighting the need for human‐focused studies to bridge translational gaps and guide regenerative medicine strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Integrated Medicine and Biochemistry, Keio University School of Medicine, Tokyo, Japan.
- Department of Gastroenterology, Keio University School of Medicine, Tokyo, Japan.
- Keio University Health Center, Tokyo, Kanagawa, Japan.
ORCID-Profile: Shinya Sugimoto, Toshiro Sato
Förderung
- Japan Society for the Promotion of Science
- AMED
- Japan Science and Technology Agency
- Japan Agency for Medical Research and Development
Zitieren
APA
Ishikawa, K., Sugimoto, S., & Sato, T. (2026). From mice to humans—divergent strategies for intestinal homeostasis and regeneration. FEBS Letters, 600(21), 3186-3200. https://doi.org/10.1002/1873-3468.70387
Vancouver
Ishikawa K, Sugimoto S, Sato T. From mice to humans—divergent strategies for intestinal homeostasis and regeneration. FEBS Letters. 2026;600(21):3186-3200. doi:10.1002/1873-3468.70387
BibTeX
@article{Ishikawa2026,
author = {Ishikawa, Keiko and Sugimoto, Shinya and Sato, Toshiro},
title = {From mice to humans—divergent strategies for intestinal homeostasis and regeneration},
journal = {FEBS Letters},
year = {2026},
volume = {600},
number = {21},
pages = {3186--3200},
doi = {10.1002/1873-3468.70387}
}
EUVIMED